EUVIMEDEUVIMED entdecken
Crossref

Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice

Jyoti Chhimwal, Rakesh Kumar Dhritlahre, Prince Anand, Ruchika, Vikram Patial, Ankit Saneja, Yogendra S Padwad

Biomaterials Advances · 2023

DOI: 10.1016/j.bioadv.2023.213627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Advances, 2023. Verfasst von Jyoti Chhimwal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Toxicology Laboratory, Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), …. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Council of Scientific & Industrial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating incidences of non-alcoholic fatty liver disease (NAFLD) and associated metabolic disorders are global health concerns. Phloretin (Ph) is a natural phenolic compound, that exhibits a wide array of pharmacological actions including its efficacy towards NAFLD. However, poor solubility and bioavailability of phloretin limits its clinical translation. Here, to address this concern we developed an amorphous solid dispersion of phloretin (Ph-SD) using Soluplus® as a polymer matrix. We further performed solid-state characterization through SEM, P-XRD, FT-IR, and TGA/DSC analysis. Phloretin content, encapsulation efficiency, and dissolution profile of the developed formulation were evaluated through reverse phase HPLC. Finally, the oral bioavailability of Ph-SD and its potential application in the treatment of experimental NAFLD mice was investigated. Results demonstrated that the developed formulation (Ph-PD) augments the dissolution profile and oral bioavailability of the native phloretin (Ph). In NAFLD mice, histopathological studies revealed the preventive effect of Ph-SD on degenerative changes, lipid accumulation, and inflammation in the liver. Ph-SD also improved the serum lipid profile, ALT, and AST levels and lowered the interleukin-6 and tumor necrosis factor-α levels in the liver. Further, Ph-SD reduced fibrotic changes in the liver tissues and attenuates NAFLD progression by blocking the mTOR/SREBP-1c pathway. In a nutshell, the results of our study strongly suggest that Ph-SD has the potential to be a therapeutic candidate in the treatment of NAFLD and can be carried forward for further clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMiceAnimalsSterol Regulatory Element Binding Protein 1Biological AvailabilityPhloretinSpectroscopy, Fourier Transform InfraredTOR Serine-Threonine KinasesLipids

Stichwörter der Autor:innen

NAFLDPhloretinSREBP-1cSoluplus®, Solid DispersionmTOR

Substanzen

Sterol Regulatory Element Binding Protein 1PhloretinTOR Serine-Threonine KinasesLipids

Autor:innen und Institutionen

  • Pharmacology and Toxicology Laboratory, Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur 176061, India; Academy of Scientific and Innovative Research…
  • Formulation Laboratory, Dietetics and Nutrition Technology Division, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur 176061, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziab…

Förderung

  • Council of Scientific & Industrial Research

Zitieren

APA

Chhimwal, J., Dhritlahre, R. K., Anand, P., Ruchika, Patial, V., Saneja, A., & Padwad, Y. S. (2023). Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice. Biomaterials Advances. https://doi.org/10.1016/j.bioadv.2023.213627

Vancouver

Chhimwal J, Dhritlahre RK, Anand P, Ruchika, Patial V, Saneja A, et al. Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice. Biomaterials Advances. 2023. doi:10.1016/j.bioadv.2023.213627

BibTeX
@article{Chhimwal2023,
  author = {Chhimwal, Jyoti and Dhritlahre, Rakesh Kumar and Anand, Prince and Ruchika and Patial, Vikram and Saneja, Ankit and Padwad, Yogendra S},
  title = {Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice},
  journal = {Biomaterials Advances},
  year = {2023},
  doi = {10.1016/j.bioadv.2023.213627}
}
Kostenlos starten →